Atlas Trials

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Clinical trial NCT05004116 · RECRUITING

Trial details

NCT number
NCT05004116
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced CancerMetastatic Solid Tumor
Start date
2021-08-09
Primary completion
2028-08-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.